Lasierra Lavilla I, Perona Caro A, Del Agua Arias-Camisón C, Caballero Castro JP. [Management of membranoproliferative glomerulonephritis secondary to infection by hepatitis C virus].
An Sist Sanit Navar 2023;
46:e1055. [PMID:
37994841 PMCID:
PMC10767695 DOI:
10.23938/assn.1055]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Revised: 08/31/2023] [Accepted: 10/18/2023] [Indexed: 11/24/2023]
Abstract
Membranoproliferative glomerulonephritis is an uncommon condition that affects the glomeruli of the kidneys; its prevalence has decreased in our environment. Membranoproliferative glomerulonephritis has a characteristic histology that can be associated to different diseases. The clinical presentation varies, and to achieve a definitive diagnosis a renal biopsy must be done. Treatment is based on the underlying disease; when a drop in glomerular filtration rate is detected, immunosuppressants are prescribed. We describe the management of a 47-year-old female with membranoproliferative glomerulonephritis secondary to hepatitis C virus infection, a condition with very low prevalence.
Collapse